CNS Summit

Researchers to Collaborate on Treatments for Brain-disorder Patients

A group of companies at the recent CNS Summit agreed to work together toward accelerated development of novel treatments.

An exciting new era of “pre-competitive collaboration” in the development of treatments for patients suffering from brain disorders began when leading enterprises and institutions involved in CNS (central nervous system) clinical trials agreed to collaborate together towards the common goal of developing novel treatments for patients, in an area of medicine with high unmet need.
The agreement to rethink how companies interact and to streamline and accelerate CNS drug development was formed at the CNS Summit 2012, which took place November 15
No votes yet
Syndicate content